BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 1975835)

  • 21. Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists.
    Nussenzveig IZ; Sircar R; Wong ML; Frusciante MJ; Javitt DC; Zukin SR
    Brain Res; 1991 Oct; 561(2):285-91. PubMed ID: 1686987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycine stimulates [3H]noradrenaline release by activating a strychnine-sensitive receptor present in rat hippocampus.
    Raiteri M; Fontana G; Fedele E
    Eur J Pharmacol; 1990 Aug; 184(2-3):239-50. PubMed ID: 2150375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different modes of action of 3-amino-1-hydroxy-2-pyrrolidone (HA-966) and 7-chlorokynurenic acid in the modulation of N-methyl-D-aspartate-sensitive glutamate receptors.
    Danysz W; Fadda E; Wroblewski JT; Costa E
    Mol Pharmacol; 1989 Dec; 36(6):912-6. PubMed ID: 2574820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NMDA receptor antagonists that bind to the strychnine-insensitive glycine site and inhibit NMDA-induced Ca2+ fluxes and [3H]GABA release.
    Reynolds IJ; Harris KM; Miller RJ
    Eur J Pharmacol; 1989 Mar; 172(1):9-17. PubMed ID: 2541002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The allosteric glycine site of the N-methyl-D-aspartate receptor modulates GABAergic-mediated synaptic events in neonatal rat CA3 hippocampal neurons.
    Gaiarsa JL; Corradetti R; Cherubini E; Ben-Ari Y
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):343-6. PubMed ID: 2153293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GV 150526A, 7-Cl-kynurenic acid and HA 966 antagonize the glycine enhancement of N-methyl-D-aspartate-induced [3H]noradrenaline and [3H]dopamine release.
    Mennini T; Mancini L; Reggiani A; Trist D
    Eur J Pharmacol; 1997 Oct; 336(2-3):275-81. PubMed ID: 9384243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different stereoselectivity of the enantiomers of HA-966 (3-amino-1-hydroxy-2-pyrrolidinone) for neuroprotective and anticonvulsant actions in vivo.
    Vartanian MG; Taylor CP
    Neurosci Lett; 1991 Nov; 133(1):109-12. PubMed ID: 1838797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
    Subramaniam S; Donevan SD; Rogawski MA
    J Pharmacol Exp Ther; 1996 Jan; 276(1):161-8. PubMed ID: 8558426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of dendritic release of dopamine by N-methyl-D-aspartate receptors in rat substantia nigra.
    Araneda R; Bustos G
    J Neurochem; 1989 Mar; 52(3):962-70. PubMed ID: 2563759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L-glutamate-evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and N-methyl-D-aspartate receptors.
    Desce JM; Godeheu G; Galli T; Artaud F; Chéramy A; Glowinski J
    Neuroscience; 1992; 47(2):333-9. PubMed ID: 1379352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competitive antagonism of glutamate receptor channels by substituted benzazepines in cultured cortical neurons.
    Swartz KJ; Koroshetz WJ; Rees AH; Huettner JE
    Mol Pharmacol; 1992 Jun; 41(6):1130-41. PubMed ID: 1352036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential modulation of the associated glycine recognition site by competitive N-methyl-D-aspartate receptor antagonists.
    Monahan JB; Biesterfeldt JP; Hood WF; Compton RP; Cordi AA; Vazquez MI; Lanthorn TH; Wood PL
    Mol Pharmacol; 1990 Jun; 37(6):780-4. PubMed ID: 2163012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A potent antagonist of the strychnine insensitive glycine receptor has anticonvulsant properties.
    Sheardown MJ; Drejer J; Jensen LH; Stidsen CE; Honoré T
    Eur J Pharmacol; 1989 Dec; 174(2-3):197-204. PubMed ID: 2560979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycine reverses antagonism of N-methyl-D-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by D-2-amino-5-phosphonovalerate (D-AP5) on rat cortical slices.
    Fletcher EJ; Lodge D
    Eur J Pharmacol; 1988 Jun; 151(1):161-2. PubMed ID: 2901361
    [No Abstract]   [Full Text] [Related]  

  • 37. 6,7-Dinitroquinoxaline-2,3-dione blocks the cytotoxicity of N-methyl-D-aspartate and kainate, but not quisqualate, in cortical cultures.
    Patel J; Zinkand WC; Klika AB; Mangano TJ; Keith RA; Salama AI
    J Neurochem; 1990 Jul; 55(1):114-21. PubMed ID: 2162373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycine-evoked neurotransmitter release from rat hippocampal brain slices: evidence for the involvement of glutaminergic transmission.
    J Pharmacol Exp Ther; ; . PubMed ID: 2156052
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.